ホーム › 前立腺がん › カリフォルニア州

カリフォルニア州における前立腺がんの臨床試験

カリフォルニア州内の拠点で、前立腺がんに関する156件の研究が参加者を募集しています。

カリフォルニア州内の都市

公式研究テキスト（英語）

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of San Diego Moores Cancer Center, La Jolla
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles

被験者募集中第1/2相

12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
他18件

被験者募集中第3相

18歳以上 · 男性 · 2026/10/02更新 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
City of Hope at Irvine Lennar, Irvine
他5件

被験者募集中第3相

18歳以上 · 男性 · 2026/10/02更新 · NCT07200830

Distance-Based Exercise to Preserve Function and Prevent Disability

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
他10件

被験者募集中

18歳以上 · 全性別 · 2026/10/02更新 · NCT07059884

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

City of Hope National Medical Center, Duarte
University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
UCLA Department of Medicine-Hematology/Oncology, Los Angeles

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
他20件

被験者募集中観察研究健康なボランティア歓迎

40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Enloe Medical Center, Chico
UC San Diego Health System - Encinitas, Encinitas
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
他4件

被験者募集中第2相

18歳以上 · 全性別 · 2026/10/02更新 · NCT06632977

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

被験者募集中第2相

18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478

Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc

City of Hope, Duarte
Cedars-Sinai Medical Center, Los Angeles

被験者募集中第2相

18歳以上 · 男性 · 2026/09/30更新 · NCT05534646

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Keck Medicine of USC Koreatown, Los Angeles
Los Angeles General Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles
他1件

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

University of California San Diego Health, San Diego

被験者募集中第4相

18歳以上 · 男性 · 2026/09/29更新 · NCT07569926

An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

被験者募集中第2相

18歳〜90歳 · 男性 · 2026/09/29更新 · NCT07185165

Precision-Based Genomics in Prostate Cancer

University of California San Diego, La Jolla
University of California San Francisco, San Francisco

被験者募集中観察研究

18歳〜120歳 · 男性 · 2026/09/28更新 · NCT04706663

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

Om Research, San Diego

被験者募集中観察研究

40歳〜75歳 · 男性 · 2026/09/28更新 · NCT07543757

DESTINY-PANTUMOUR04

Research Site, San Diego

被験者募集中観察研究

18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Research Site, Los Angeles

被験者募集中第1/2相

18歳〜130歳 · 男性 · 2026/09/25更新 · NCT07181161

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

University of California San Diego, Moores Cancer Center, La Jolla

被験者募集中第1相

18歳以上 · 男性 · 2026/09/25更新 · NCT06801236

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 0120), Irvine
UCLA Hematology/Oncology - Santa Monica ( Site 0044), Los Angeles
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040), Orange
他4件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06136650

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

UCLA Hematology/Oncology - Alhambra, Alhambra
UCLA Hematology/Oncology - Atascadero, Atascadero
Cedars-Sinai Cancer Beverly Hills (drug treatment and dispensing location), Beverly Hills
他20件

被験者募集中第3相

18歳以上 · 男性 · 2026/09/24更新 · NCT07028853